Antihypertensive therapy and progression of chronic renal disease.

Abstract:

:This paper reviews findings on the relationship between blood pressure control and the progression of renal disease. Experimental studies demonstrate a correlation between systemic blood pressure and histologic glomerular injury and the delay in progression of renal disease with antihypertensive therapy, particularly with angiotensin-converting enzyme inhibitors. Recent clinical findings are reviewed, including epidemiologic data linking hypertension to subsequent renal disease, and clinical studies showing a beneficial effect on progression of renal disease with lower than usual blood pressure targets.

journal_name

Curr Hypertens Rep

authors

Dworkin LD,Shemin DG

doi

10.1007/s11906-999-0058-x

keywords:

subject

Has Abstract

pub_date

1999-10-01 00:00:00

pages

417-22

issue

5

eissn

1522-6417

issn

1534-3111

journal_volume

1

pub_type

杂志文章
  • Effects of relaxin on arterial dilation, remodeling, and mechanical properties.

    abstract::Administering relaxin to conscious rats and humans elicits systemic and renal vasodilation. The molecular mechanisms vary according to the duration of relaxin exposure-so-called "rapid" (within minutes) or "sustained" (hours to days) vasodilatory responses-both being endothelium-dependent. Rapid responses are mediated...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-011-0231-x

    authors: Conrad KP,Shroff SG

    更新日期:2011-12-01 00:00:00

  • Is population-wide diuretic use directly associated with the incidence of end-stage renal disease in the United States?

    abstract::In the quest for "evidence-based" medicine, an accepted hierarchy of evidence has been proposed. This hierarchy places in vitro studies and animal data at the base, and puts systematic reviews, meta-analyses, and randomized controlled trials at the pinnacle. However, when clinical medicine faces questions that have no...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-006-0054-3

    authors: Hawkins RG

    更新日期:2006-06-01 00:00:00

  • Pathophysiology of obesity hypertension.

    abstract::Excess weight gain is a major cause of essential hypertension, and abnormal kidney function appears to be a cause as well as a consequence of obesity hypertension. Excess renal sodium reabsorption and a hypertensive shift of pressure natriuresis play a major role in mediating increased blood pressure associated with w...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-000-0073-4

    authors: Hall JE

    更新日期:2000-04-01 00:00:00

  • Hypertension in postmenopausal women.

    abstract::Blood pressure is typically lower in premenopausal women than in men. However, after menopause, the prevalence of hypertension in women is higher than it is in men. Hypertension is a major risk factor for cardiovascular disease in women and men, but cardiovascular disease is the leading cause of death in women. Furthe...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-012-0260-0

    authors: Lima R,Wofford M,Reckelhoff JF

    更新日期:2012-06-01 00:00:00

  • Blood Pressure and Statin Effects on Cognition: a Review.

    abstract:PURPOSE OF REVIEW:This is a review of available data on the effects of blood pressure and statins on cognition. RECENT FINDINGS:Recent randomized clinical trials have shown that intensive control of systolic blood pressure in older adults prevented the development of mild cognitive impairment (MCI) and the combined ef...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-019-0973-4

    authors: Yang M,Williamson J

    更新日期:2019-07-26 00:00:00

  • Diastolic pressure, systolic pressure, or pulse pressure?

    abstract::Diastolic pressure, systolic pressure, and pulse pressure have all been assigned the role of the best predictor of cardiovascular events during the 20th century. At the dawn of the new millennium, concepts that draw attention to vascular mechanics reconcile the seemingly conflicting results of epidemiologic studies, b...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-000-0010-6

    authors: Vlachopoulos C,O'Rourke M

    更新日期:2000-06-01 00:00:00

  • The use of calcium antagonists in the treatment of hypertensive persons with kidney disease.

    abstract::The treatment of hypertension is proven to reduce cardiovascular and renal risk. Combination drug therapy is becoming recognized as a necessity in most patients with hypertension and kidney disease. Allegations about the safe use of calcium antagonists in patients with kidney disease have led to questions and confusio...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-002-0006-5

    authors: Tobe S,Epstein M

    更新日期:2002-06-01 00:00:00

  • Resistant hypertension and the Birmingham Hypertension Square.

    abstract::Recent guidelines for the treatment of hypertension place great emphasis on tighter blood pressure control, especially in the presence of hypertensive target organ damage and diabetes. In order to achieve these treatment targets, more patients will require a combination of antihypertensive medications. However, resist...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-001-0039-1

    authors: Felmeden DC,Lip GY

    更新日期:2001-06-01 00:00:00

  • Dysfunctional brain-bone marrow communication: a paradigm shift in the pathophysiology of hypertension.

    abstract::It is widely accepted that the pathophysiology of hypertension involves autonomic nervous system dysfunction, as well as a multitude of immune responses. However, the close interplay of these systems in the development and establishment of high blood pressure and its associated pathophysiology remains elusive and is t...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-013-0361-4

    authors: Santisteban MM,Zubcevic J,Baekey DM,Raizada MK

    更新日期:2013-08-01 00:00:00

  • Chronic kidney disease and albuminuria in arterial hypertension.

    abstract::Chronic kidney disease is a major public health problem worldwide: it is estimated that in the general population, 1 person in 10 has some degree of renal damage. Adequate blood pressure control represents the mainstay of treatment, to delay deterioration of renal function and prevent cardiovascular complications. Cur...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-010-0141-3

    authors: Leoncini G,Viazzi F,Pontremoli R

    更新日期:2010-10-01 00:00:00

  • New-onset diabetes in treated hypertensive patients.

    abstract::Interpretation of some recent trials in hypertension opened a debate on the clinical value of new-onset diabetes in treated hypertensive patients. It is not completely clear whether certain antihypertensive drug classes are associated with a higher risk for developing type 2 diabetes when compared with other classes. ...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-005-0006-3

    authors: Verdecchia P,Angeli F,Reboldi GP,Gattobigio R

    更新日期:2005-06-01 00:00:00

  • The epithelial sodium channel in hypertension.

    abstract::Our understanding of Na(+) transport defects has exploded in the past several years, and has provided unique insights into epithelial transport processes, and unusual clinical syndromes resulting from mutations of specific ion transporters. These genetic disorders affect Na(+) balance, with both Na(+) retaining and Na...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-999-0013-x

    authors: Warnock DG

    更新日期:1999-04-01 00:00:00

  • Hypertensive renal damage: insights from animal models and clinical relevance.

    abstract::Investigations using chronic blood pressure (BP) radiotelemetry in conscious animals have provided substantial insights into the pathophysiology of hypertensive renal damage. Normal renal autoregulation protects the renal microvasculature from significant injury in most patients with primary hypertension, unless BP ex...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-004-0091-8

    authors: Griffin KA,Bidani AK

    更新日期:2004-04-01 00:00:00

  • Ongoing trials: what should we expect after ALLHAT?

    abstract::The publication of the Antihypertensive and Lipid-lowering Treatment to Prevent Heart Attack Trial (ALLHAT) results, when used in conjunction with a new meta-analysis, provides hypertension research with a watershed. Data demonstrate clearly that lowering blood pressure is the most important aspect of hypertension man...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,meta分析

    doi:10.1007/s11906-003-0044-7

    authors: Wang JG,Staessen JA,Heagerty AM

    更新日期:2003-08-01 00:00:00

  • Relationship Between Antihypertensive Medications and Cognitive Impairment: Part I. Review of Human Studies and Clinical Trials.

    abstract:PURPOSE OF REVIEW:There is an established association between hypertension and increased risk of poor cognitive performance and dementia including Alzheimer's disease; however, associations between antihypertensive medications (AHMs) and dementia risk are less consistent. An increased interest in AHM has resulted in ex...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-016-0674-1

    authors: Yasar S,Schuchman M,Peters J,Anstey KJ,Carlson MC,Peters R

    更新日期:2016-08-01 00:00:00

  • Mineralocorticoid Receptor and Endothelial Dysfunction in Hypertension.

    abstract:PURPOSE OF REVIEW:To review the latest reports of the contributions of the endothelial mineralocorticoid receptor to endothelial dysfunction and hypertension to begin to determine the clinical potential for this pathway for hypertension treatment. RECENT FINDINGS:Endothelial mineralocorticoid receptor expression is se...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-019-0981-4

    authors: Faulkner JL,Belin de Chantemèle EJ

    更新日期:2019-09-04 00:00:00

  • Renin inhibitors: optimal strategy for renal protection.

    abstract::Diabetic nephropathy and hypertension are the major causes of chronic kidney disease. The renin system plays a key role in the control of blood pressure (BP), as well as in the regulation of renal and adrenal function. Chronic activation of the renin system can lead to organ damage, particularly renal damage; increasi...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-007-0076-5

    authors: Schmieder RE

    更新日期:2007-11-01 00:00:00

  • Dual blockade of the renin angiotensin system in diabetic and nondiabetic kidney disease.

    abstract::Dual blockade of the renin angiotensin system is based on a principle of obtaining the broadest and most efficient blockade of the effects of angiotensin II, by using the combination of an angiotensin-converting enzyme (ACE) inhibitor and an angiotensin II-receptor blocker (ARB). By combining two, different pharmacolo...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-004-0056-y

    authors: Andersen NH,Mogensen CE

    更新日期:2004-10-01 00:00:00

  • Endogenous ouabain: a link between sodium intake and hypertension.

    abstract::The sodium pump, an ancestral enzyme with conserved ability to bind ouabain, plays a key role in salt conservation and is regulated by aldosterone and endogenous ouabain (EO). Plasma EO is elevated in about 45% of patients with essential hypertension and correlates with blood pressure. The relationship of EO with Na(+...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-010-0161-z

    authors: Hamlyn JM,Manunta P

    更新日期:2011-02-01 00:00:00

  • Statins and blood pressure regulation.

    abstract::Hypertension and high serum cholesterol levels are two of the most relevant risk factors for cardiovascular diseases. A combined increase in both risk factors has been reported in a significant proportion of patients with coronary artery disease. Statins are the most widely used drugs to treat hypercholesterolemia, an...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-001-0090-y

    authors: Borghi C,Veronesi M,Prandin MG,Dormi A,Ambrosioni E

    更新日期:2001-08-01 00:00:00

  • Leptin: linking obesity, the metabolic syndrome, and cardiovascular disease.

    abstract::The incidence and prevalence of obesity and the metabolic syndrome have risen markedly in the past decade, representing a serious cardiovascular health hazard with significant morbidity and mortality. The etiology of the metabolic syndrome and its various pathogenic mechanisms are incompletely defined and under intens...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-008-0025-y

    authors: Patel SB,Reams GP,Spear RM,Freeman RH,Villarreal D

    更新日期:2008-04-01 00:00:00

  • Integrative Physiological Aspects of Brain RAS in Hypertension.

    abstract:PURPOSE OF REVIEW:The renin-angiotensin system (RAS) plays an important role in modulating cardiovascular function and fluid homeostasis. While the systemic actions of the RAS are widely accepted, the role of the RAS in the brain, its regulation of cardiovascular function, and sympathetic outflow remain controversial. ...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-018-0810-1

    authors: de Morais SDB,Shanks J,Zucker IH

    更新日期:2018-02-26 00:00:00

  • The role of aldosterone in the metabolic syndrome.

    abstract::The metabolic syndrome associates metabolic abnormalities such as insulin resistance and dyslipidemia with increased waist circumference and hypertension. It is a major public health concern, as its prevalence could soon reach 30% to 50% in developed countries. Aldosterone, a mineralocorticoid hormone classically invo...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-011-0182-2

    authors: Briet M,Schiffrin EL

    更新日期:2011-04-01 00:00:00

  • Elucidating the Pathogenesis of Pre-eclampsia Using In Vitro Models of Spiral Uterine Artery Remodelling.

    abstract:PURPOSE OF REVIEW:The aim of the study is to perform a critical assessment of in vitro models of pre-eclampsia using complementary human and cell line-based studies. Molecular mechanisms involved in spiral uterine artery (SUA) remodelling and trophoblast functionality will also be discussed. RECENT FINDINGS:A number o...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-017-0786-2

    authors: McNally R,Alqudah A,Obradovic D,McClements L

    更新日期:2017-10-23 00:00:00

  • The "J curve" problem revisited: old and new findings.

    abstract::This paper critically addresses the issue of the "J-curve" paradox--the finding described in studies performed about 30 years ago indicating that treatment-induced systolic blood pressure values below 120 or 125 mm Hg and diastolic blood pressure values below 75 mm Hg are characterized by an increase, rather than a re...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-010-0121-7

    authors: Grassi G,Quarti-Trevano F,Dell'Oro R,Mancia G

    更新日期:2010-08-01 00:00:00

  • Pulse pressure, heart rate, and drug treatment of hypertension.

    abstract::Peak-systolic blood pressure (SBP) and end-diastolic blood pressure (DBP) have been considered the exclusive mechanical factors predicting cardiovascular (CV) risk in populations of normotensive and hypertensive subjects. The purpose of this review is to show that in addition to SBP and DBP, other hemodynamic indices ...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-004-0068-7

    authors: Safar ME

    更新日期:2004-06-01 00:00:00

  • Angiotensin II and progressive renal insufficiency.

    abstract::The inhibition of angiotensin II through angiotensin converting enzyme inhibitors or angiotensin receptor blockers has become the foundation of medical treatment of progressive chronic renal disease. Although these drugs provide a significant improvement over earlier treatments, they only slow the progression of renal...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-002-0071-9

    authors: Gaedeke J,Noble NA,Border WA

    更新日期:2002-10-01 00:00:00

  • From Clinical Trials to Bedside: the Use of Antihypertensives in Aged Individuals. Part 2: Approach to Treatment.

    abstract:PURPOSE OF REVIEW:Use of antihypertensives in older adults can be complicated by the potential for undesired effects on comorbidities, adverse effects of the drugs, and overall medication burden. The purpose of this two-part review is to discuss contemporary issues encountered in the management of hypertension in aged ...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-019-0988-x

    authors: Ernst ME,MacLaughlin EJ

    更新日期:2019-10-10 00:00:00

  • Angiotensin-receptor blocking agents and the peroxisome proliferator-activated receptor-gamma system.

    abstract::The metabolic syndrome leads to cardiovascular disease and type 2 diabetes mellitus, through multiple risks, such as insulin resistance, dyslipidemia, hyperinsulinemia, and hypertension. It also represents a disorder of partial genetic background as mutations of the peroxisome proliferator-activated receptor-gamma (PP...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-005-0019-y

    authors: Tuck ML

    更新日期:2005-08-01 00:00:00

  • Compliance and persistence with newer antihypertensive agents.

    abstract::Individuals with hypertension need to stay on therapy with antihypertensive medication to obtain the full benefits of blood pressure reduction. There are important differences in tolerability across antihypertensive drug classes, and these differences influence the extent to which patients are willing to continue taki...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-002-0021-6

    authors: Gerth WC

    更新日期:2002-12-01 00:00:00